Oritani Financial (ORIT) 16.97 $ORIT Top Lender Oritani

New Post Public Reply Private Reply Replies (0) Message Board

Apr 1, 2016 at 2:42 AM

Oritani Financial (ORIT) 16.97 $ORIT

Top Lender Oritani Financial Holds Near Buy Point
at Investor's Business Daily - Thu Mar 10, 2:44PM CST
Oritani Financial (ORIT), the holding company for New Jersey-based Oritani Bank, is near a buy point despite a weak profit outlook. The stock is about 2% below a flat base entry at 17.53. However, it's thinly traded and lacks strong institutional...
ORIT: 16.97 (-0.24)

Oritani posts 2Q profit
Automated Insights - Tue Jan 26, 7:21AM CST
TOWNSHIP OF WASHINGTON, N.J. (AP) _ Oritani Financial Corp. (ORIT) on Tuesday reported fiscal second-quarter earnings of $15.9 million.
ORIT: 16.97 (-0.24)

Oritani Financial Corp. Announces 2nd Quarter Results and Dividend
GlobeNewswire - Tue Jan 26, 7:00AM CST
Oritani Financial Corp. (the "Company" or "Oritani"

(NASDAQ:ORIT), the holding company for Oritani Bank (the "Bank"

, reported net income of $15.9 million, or $0.38 per basic (and $0.37 diluted) common share, for the three months ended December 31, 2015, and $28.0 million, or $0.68 per basic (and $0.66 diluted) common share, for the six months ended December 31, 2015. Net income was $10.0 million, or $0.24 per basic and diluted common share, for the three months ended December 31, 2014, and $20.2 million, or $0.48 per basic (and $0.47 diluted) common share, for the six months ended December 31, 2014.
ORIT: 16.97 (-0.24)

Oritani Financial Corp. Announces $0.50 Special Dividend
GlobeNewswire - Tue Nov 24, 8:30AM CST
Oritani Financial Corp. (the "Company" or "Oritani"

(NASDAQ:ORIT), the holding company for Oritani Bank (the "Bank"

announced that its Board of Directors has declared a special cash dividend of $0.50 per share on the Company's common stock. The record date for the dividend will be December 4, 2015 and the payment date will be December 18, 2015.
ORIT: 16.97 (-0.24)

Downgrade Alert for Oritani Financial (ORIT)
Comtex SmarTrend(R) - Wed Oct 28, 7:11AM CDT
Oritani Financial (NASDAQ:ORIT) was downgraded from Buy to Hold at Sandler O'Neill today. The stock closed yesterday at $16.09 on volume of 383,000 shares, above average daily volume of 148,000. Oritani Financial Corporation is the bank holding company. The Bank attracts deposits, originates various loans, and invests in securities.
ORIT: 16.97 (-0.24)

Oritani Financial Corp. Announces Dividend and Quarterly Results
GlobeNewswire - Mon Oct 26, 3:58PM CDT
Oritani Financial Corp. (the "Company" or "Oritani"

(NASDAQ:ORIT), the holding company for Oritani Bank (the "Bank"

, reported net income of $12.2 million, or $0.30 per basic (and $0.29 diluted) common share, for the three months ended September 30, 2015. Net income was $10.2 million, or $0.24 per basic and diluted common share, for the corresponding 2014 period.
ORIT: 16.97 (-0.24)

BUYINS.NET: XBI, RPG, QQEW, QLD, COWN, ORIT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Sep 08, 7:15AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Spdr S&P Biotech Etf (NYSE:XBI), Ram Power Corp (NYSE:RPG), First Trust Portfolios LP (NASDAQ:QQEW), ProShares Ultra QQQ (NYSE:QLD), Cowen Group Inc (NASDAQ:COWN), Oritani Financial Corp (NASDAQ:ORIT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
COWN: 3.81 (+0.05), QLD: 73.80 (-0.23), ORIT: 16.97 (-0.24), XBI: 51.66 (+1.49), QQEW: 42.23 (+0.09), RPG: 79.40 (-0.07)

Why Oritani Financial (ORIT) Could Beat Earnings Estimates Again
Zacks Equity Research - Zacks Investment Research - Thu Aug 13, 7:34AM CDT
Oritani Financial in the Banks - Northeast space might be in a good position to beat earnings at its next report
ORIT: 16.97 (-0.24)

Oritani Financial Corp. Reports Record Earnings and Dividend
GlobeNewswire - Mon Jul 27, 7:00AM CDT
Oritani Financial Corp. (the "Company" or "Oritani"

(NASDAQ:ORIT), the holding company for Oritani Bank (the "Bank"

, reported net income of $15.7 million, or $0.38 per basic (and $0.37 diluted) common share, for the three months ended June 30, 2015, and $46.9 million, or $1.13 per basic (and $1.10 diluted) common share, for the twelve months ended June 30, 2015. This compares to net income of $10.0 million, or $0.23 per basic and diluted common share for the three months ended June 30, 2014 and net income of $41.1 million, or $0.96 per basic (and $0.94 diluted) common share for the twelve months ended June 30, 2014.
ORIT: 16.97 (-0.24)

BUYINS.NET: XLG, LHCG, DISCA, CQP, CIU, ORIT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jun 26, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Guggenheim Invest Russell Top 50 ETF (NYSE:XLG), LHC GROUP, INC. (NASDAQ:LHCG), Discovery Communications Inc (NASDAQ

ISCA), Cheniere Energy Partners LP (NYSE:CQP), Ishares Barclays Intermediate Credit Bond Fund (NYSE:CIU), Oritani Financial Corp (NASDAQ:ORIT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CQP: 28.84 (+0.56), LHCG: 35.56 (+0.15), ORIT: 16.97 (-0.24), DISCA: 28.63 (+0.54), CIU: 109.69 (+0.26), XLG: 145.34 (-0.47)

Upgrade Alert for Oritani Financial (ORIT)
Comtex SmarTrend(R) - Fri Apr 24, 7:28AM CDT
Oritani Financial (NASDAQ:ORIT) was upgraded from Hold to Buy at Sandler O'Neill today. The stock closed yesterday at $15.68 on volume of 464,000 shares, above average daily volume of 176,000. Oritani Financial (NASDAQ:ORIT) is currently priced 0.6% above its average consensus analyst price target of $15.58. The stock should find initial support at its 200-day moving average (MA) of $14.63 and further support at its 50-day MA of $14.56.
ORIT: 16.97 (-0.24)

Oritani Financial Corp. Reports Earnings and Dividend
GlobeNewswire - Wed Apr 22, 3:05PM CDT
Oritani Financial Corp. (the "Company" or "Oritani"

(Nasdaq:ORIT), the holding company for Oritani Bank (the "Bank"

, reported net income of $11.0 million, or $0.26 per basic and diluted common share, for the three months ended March 31, 2015, and $31.2 million, or $0.75 per basic (and $0.73 diluted) common share, for the nine months ended March 31, 2015. This compares to net income of $10.7 million, or $0.25 per basic and diluted common share for three months ended March 31, 2014 and net income of $31.1 million, or $0.73 per basic (and $0.71 diluted) common share for the nine month period ended March 31, 2014.
ORIT: 16.97 (-0.24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...